General Court (President of the Chamber) 29 February 2024, T-1182/23 R (Neuraxpharm Pharmaceuticals SL v European Commission.)

ORDER OF THE PRESIDENT OF THE GENERAL COURT 29 February 2024 (*) (Interim relief – Medicinal products for human use – Marketing authorisation for ‘Dimethyl fumarate Neuraxpharm – dimethyl fumarate’ – Application for suspension of operation of a measure – No urgency) In Case T‑1182/23 R, Neuraxpharm Pharmaceuticals, SL, established in Barcelona (Spain), represented by K. Roox, T. De Meese, J.